Lam Research Corporation LRCX Receives Analyst Upgrades Amid Oversold Growth Stock Discussion Traders on Prediction Markets See Rising Odds of Fed Rate Hike by July 2027 Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement in CNBC Interview BioOrbit Launches Drug Crystallization Technology on SpaceX to Space Station Targeting SelfInjected Cancer Treatments Agri Gold Loans See 40 Growth as Farmers Leverage Rising Bullion Prices Mercury Reaches 52 Billion Valuation in Latest Funding Round Signaling Resilience in Fintech Sector BCC Q1 2026 Earnings EPS Surges Past Estimates with 1826 Surprise DTE Energy Q1 2026 Earnings Earnings Miss Estimates as Costs Pressure Results A2Z Cust2Mate Solutions AZ Q3 2025 Earnings Loss Per Share of 007 Amidst Ongoing Investment Phase PFXNZ Q1 2026 Earnings Strong EPS Beat on Improved Investment Income ACHC Q1 2026 Earnings Strong EPS Beat Amid Operational Improvements UHT Q1 2026 Earnings Steady PerShare Results Amidst Stable Healthcare Real Estate Septerna Inc SEPN Surges 8 as Bullish Momentum Builds Soren Acquisition Corp SORN Holds Steady at 992 Amid Low Volatility Grupo Cibest CIB Slides 13 ADR Tests Key Support as Sector Headwinds Persist Wellchange Holdings WCT Faces Sharp Decline Key Levels Under Pressure Invesco Advantage Municipal Income Trust II VKI Posts Modest Gain Navigating Yield Opportunities and Key Technical Levels Select Water Solutions Q1 2026 Earnings EPS Smashes Estimates Despite Stock Pullback FFAI Q1 2026 Earnings EPS Surprises by Nearly 70 but Stock Sinks Amid Missing Revenue Teads Holding Co TEAD Q1 2026 Earnings EPS Surprises Positively but Stock Falters CIMN Q1 2026 Earnings EPS Beats Estimates by 282 The Chefs Warehouse Inc CHEF Q1 2026 Earnings Strong Profit Beat Drives Cautious Optimism TriplePoint Venture Growth BDC Corp TPVG Q1 2026 Earnings EPS Misses Estimates Amid Venture Debt Market Pressures JDcom JD Gains Attention as a Potential Value Play Among NASDAQ Stocks ATNM Q1 2026 Earnings NarrowerthanExpected Loss Highlights Controlled Spending Amid Clinical Progress Constellium CSTM Rallies 3 Approaching Key Resistance at 3673